siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytes

ACS Chemical Biology
Shigeo MatsudaMuthiah Manoharan

Abstract

Asialoglycoprotein receptor (ASGPR) mediated delivery of triantennary N-acetylgalactosamine (GalNAc) conjugated short interfering RNAs (siRNAs) to hepatocytes is a promising paradigm for RNAi therapeutics. Robust and durable gene silencing upon subcutaneous administration at therapeutically acceptable dose levels resulted in the advancement of GalNAc-conjugated oligonucleotide-based drugs into preclinical and clinical developments. To systematically evaluate the effect of display and positioning of the GalNAc moiety within the siRNA duplex on ASGPR binding and RNAi activity, nucleotides carrying monovalent GalNAc were designed. Evaluation of clustered and dispersed incorporation of GalNAc units to the sense (S) strand indicated that sugar proximity is critical for ASGPR recognition, and location of the clustered ligand impacts the intrinsic potency of the siRNA. An array of nucleosidic GalNAc monomers resembling a trivalent ligand at or near the 3' end of the S strand retained in vitro and in vivo siRNA activity, similar to the parent conjugate design. This work demonstrates the utility of simple, nucleotide-based, cost-effective siRNA-GalNAc conjugation strategies.

References

Jul 9, 2004·Nature·Carl D Novina, Phillip A Sharp
Nov 17, 2006·Nature Chemical Biology·David BumcrotDinah W Y Sah
Sep 8, 2010·Methods in Enzymology·Prabhjit K Grewal
Feb 9, 2011·The Journal of Organic Chemistry·Takeshi YamadaKallanthottathil G Rajeev
Aug 28, 2012·Chemistry & Biology·Glen F Deleavey, Masad J Damha
Dec 21, 2012·Chemical Society Reviews·Nicolas SpinelliFrançois Morvan
Mar 29, 2014·Expert Opinion on Drug Delivery·Christoffer NielsenNiels Behrendt
Jul 16, 2014·Biotechnology & Genetic Engineering Reviews·B H Joshi, K P Pachchigar
Dec 2, 2014·Journal of the American Chemical Society·Jayaprakash K NairMuthiah Manoharan
Mar 20, 2015·Chembiochem : a European Journal of Chemical Biology·Kallanthottathil G RajeevMuthiah Manoharan

❮ Previous
Next ❯

Citations

Sep 19, 2015·Nucleic Acids Research·John R AndrosavichB Nelson Chau
Oct 30, 2015·Future Medicinal Chemistry·Vivek K Sharma, Jonathan K Watts
Mar 8, 2016·ACS Chemical Biology·Frederic GeinguenaudLaurence Motte
Oct 18, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Samantha M SarettCraig L Duvall
May 27, 2015·Bioconjugate Chemistry·Michael E ØstergaardPunit P Seth
Aug 19, 2015·Nature Reviews. Genetics·Anders Wittrup, Judy Lieberman
Apr 17, 2016·Nucleic Acids Research·Rudolph L Juliano
Jan 23, 2016·Chemical Biology & Drug Design·Takanori KuboToshio Seyama
Jun 19, 2016·Biochimie·Elena M SmekalovaVictor Koteliansky
Jul 3, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tsukasa SugoHirokazu Matsumoto
Aug 16, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Matt GoodingCaitriona M O'Driscoll
Nov 5, 2016·The Journal of Organic Chemistry·Laurence ArzelJacques Lebreton
Dec 15, 2016·Bioconjugate Chemistry·Xiangang HuangBastien Castagner
Dec 3, 2016·Nucleic Acids Research·Socheata LyAnastasia Khvorova
Feb 24, 2017·Journal of the American Chemical Society·Carlos A SanhuezaVincent Mascitti
Mar 1, 2017·Nature Biotechnology·Anastasia Khvorova, Jonathan K Watts
Apr 6, 2017·Chemical Biology & Drug Design·Chelliah SelvamRamasamy Thilagavathi
May 23, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rajesh KumarJesper Wengel
Apr 18, 2018·Nature Structural & Molecular Biology·Judy Lieberman
May 5, 2018·Expert Opinion on Drug Delivery·Kevin CraigMansoor Amiji
Feb 21, 2018·Nature Communications·Maja M JanasVasant Jadhav
May 25, 2018·Nucleic Acid Therapeutics·Aaron D Springer, Steven F Dowdy
Sep 19, 2019·Current Protocols in Nucleic Acid Chemistry·Tsuyoshi YamamotoSatoshi Obika
Nov 20, 2018·Nature Biotechnology·Anton A TuranovAnastasia Khvorova
Dec 14, 2018·Nucleic Acids Research·Annabelle BiscansAnastasia Khvorova
May 31, 2019·Expert Opinion on Drug Metabolism & Toxicology·Yanfeng WangRichard S Geary
Jan 29, 2019·The Journal of Clinical Investigation·Punit P SethC Frank Bennett
Mar 18, 2020·Chembiochem : a European Journal of Chemical Biology·Ander Maguregui, Hiroshi Abe
Apr 7, 2020·Journal of Alzheimer's Disease : JAD·Margaret F BassendineDermot Neely
Aug 13, 2020·Nature Reviews. Drug Discovery·Thomas C RobertsMatthew J A Wood
Jun 8, 2017·Nucleic Acids Research·Reka A HarasztiAnastasia Khvorova

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved